Keywords: Takeda, URL Pharma generics business, Sun Pharmaceutical, Eisai, Arbor Pharma, Gliadel, USA, Glioma
Takeda sells non-Colcrys URL Pharma generic business to Sun Pharma; Eisai divests Gliadel Wafer in USA
Article | 17 December 2012
Japan’s largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement with Caraco Pharmaceutical Laboratories, a wholly-owned ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
